Wnt signaling: a key regulator of bone mass
- PMID: 17118265
- DOI: 10.1016/S0070-2153(06)76004-5
Wnt signaling: a key regulator of bone mass
Abstract
The identification of a link between bone mass in humans and gain- [high bone mass (HBM) trait] or loss-of-function [osteoporosis pseudoglioma (OPPG) syndrome] mutations in the Wnt coreceptor lipoprotein receptor-related protein (LRP)5 or in the Wnt antagonist sclerostin (sclerosteosis, Van Buchem syndrome) has called the attention of academic and industry scientists and clinicians to the importance of this signaling pathway in skeletal biology and disease. Multiple genetic and pharmacological manipulations of Wnt signaling in mice have since then confirmed the central role of this pathway in both the establishment of peak bone mass and its maintenance throughout life. Wnt signaling appears to be located downstream of bone morphogenetic proteins (BMPs), itself induced by Hedgehog (Hh) signaling, suggesting that it is the successive recruitment of these three intracellular signaling cascades that allow the full expression of the genetic patterns that characterize the osteoblast, the cell responsible for the formation of bone.
Similar articles
-
[Wnt-beta-catenin signaling in bone metabolism].Clin Calcium. 2006 Jan;16(1):54-60. Clin Calcium. 2006. PMID: 16397351 Review. Japanese.
-
Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.Bone. 2008 Apr;42(4):669-80. doi: 10.1016/j.bone.2007.12.006. Epub 2007 Dec 27. Bone. 2008. PMID: 18294945
-
Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.Endocrinology. 2007 Jun;148(6):2635-43. doi: 10.1210/en.2007-0270. Epub 2007 Mar 29. Endocrinology. 2007. PMID: 17395698 Review.
-
The Wnt signaling pathway and bone metabolism.Curr Opin Rheumatol. 2007 Jul;19(4):376-82. doi: 10.1097/BOR.0b013e32816e06f9. Curr Opin Rheumatol. 2007. PMID: 17551370 Review.
-
Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.J Bone Miner Res. 2009 Oct;24(10):1651-61. doi: 10.1359/jbmr.090411. J Bone Miner Res. 2009. PMID: 19419300
Cited by
-
Role of calcitonin gene-related peptide in functional adaptation of the skeleton.PLoS One. 2014 Dec 23;9(12):e113959. doi: 10.1371/journal.pone.0113959. eCollection 2014. PLoS One. 2014. PMID: 25536054 Free PMC article.
-
Characterization of Dkk1 gene regulation by the osteoblast-specific transcription factor Osx.Biochem Biophys Res Commun. 2012 Apr 20;420(4):782-6. doi: 10.1016/j.bbrc.2012.03.073. Epub 2012 Mar 20. Biochem Biophys Res Commun. 2012. PMID: 22459449 Free PMC article.
-
Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.J Bone Miner Res. 2011 Jul;26(7):1425-36. doi: 10.1002/jbmr.345. J Bone Miner Res. 2011. PMID: 21312267 Free PMC article.
-
SHP2 Regulates the Osteogenic Fate of Growth Plate Hypertrophic Chondrocytes.Sci Rep. 2017 Oct 5;7(1):12699. doi: 10.1038/s41598-017-12767-9. Sci Rep. 2017. PMID: 28983104 Free PMC article.
-
Isopsoralen ameliorates H2O2-induced damage in osteoblasts via activating the Wnt/β-catenin pathway.Exp Ther Med. 2019 Sep;18(3):1899-1906. doi: 10.3892/etm.2019.7741. Epub 2019 Jul 5. Exp Ther Med. 2019. PMID: 31410152 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous